| BioCommerce Data Ltd |
 |
| BioSpace,
Inc. is a specialized provider of web-based products and information
services to the life sciences. The company’s premier Website,
www.biospace.com
is the Internet’s most comprehensive life sciences-related
information and service resource, attracting 800,000 unique visitors
and over 4 million page views monthly. Recognizing the tidal wave
of information being published in the life sciences, BioSpace has
developed products and services that more efficiently deliver information
in a context that is relevant to the end user. Offered both on the
Internet, or an enterprise Intranet, BioSpace’s suite of Enterprise
Portal Services includes an information management tool called BioSpace
LInKS™ Solution, and CCIS, a Clinical Competitive Intelligence
System. Additionally the company leverages its extensive online
community to offer highly popular life sciences industry Career
Fairs. San Francisco-based BioSpace.com was launched in 1995. |
 |
| Biotechnology Investment Today Biotechnology Investment Today is a quarterly review journal for stakeholders in the biotechnology industry. The magazine covers therapeutic and technology sectors within the industry as well as critical operational and financing issues that directly affect company and shareholder value. Topics covered in recent issues include: Cancer Therapeutics, Pharmacogenomics, M&A, Capital Markets and Pathways to Market. The magazine also covers emerging markets and in 2002 will review Australia, Israel, Singapore and Japan. Biotechnology Investment Today is supported by a global seminar and investor network series with events held regularly in the US and Europe. |
 |
| BioVenture View is the definitive twice-monthly newsletter for the global biotechnology industry and has been providing senior executives with the information they need to stay ahead of the competition. Each monthly issue provides an informative and incisive package of analysis and data, including:
|
 |
| BioWorld Today BioWorld Today, the newspaper of record for the biotechnology industry, is read by thousands of biotechnology professionals worldwide for its hard-hitting, objective news reporting. BioWorld Today is delivered by fax and e-mail every business morning, and is also found exclusively online at www.BioWorld.com. The BioWorld Online web site has been internationally recognized as the most comprehensive resource for strategic biotechnology news and information available today. In addition to original daily news reporting, BioWorld offers an extensive searchable database with more than 11 years of biotechnology archives. This site is not only a great source for insightful, up-to-the-minute news coverage, but a veritable library of information on the developments of the industry as well. With a quick search, BioWorld subscribers have instant access to a wealth of biotechnology market intelligence from every biotech hotspot around the globe. BioWorld does not post press releases, but rather uses information that is researched and written by the top business and science reporters in the industry. With nearly 20 writers spread throughout eight countries, BioWorld covers news on public companies and hard-to-find information on private companies. Our seasoned reporters get the inside scoop on what’s happening within the corporate walls, on regulatory issues in Washington and elsewhere, and on scientific breakthroughs worldwide. This news coverage of the biotechnology industry is 100% original and only available at BioWorld! BioWorld Products:
|
 |
| BusinessWire Business Wire disseminates full-text news announcements from thousands of companies and organizations worldwide to news media, financial markets, disclosure systems, investors, information web sites, databases and other audiences. Our BioWire2K circuits, developed by Business Wire in conjunction with Mary Ann Liebert, Inc., publisher of Genetic Engineering News and authoritative peer-reviewed journals, provides expertise, unparalleled contacts and proprietary databases to ensure that your industry news reaches key biotech media around the globe. |
 |
| Clinica Reports Profile to follow shortly |
 |
| Genomika Available electronically and in print, Genomika is an up-to-the-minute newsletter providing an informative and incisive package of news and analysis on the fast-expanding field of drug discovery technologies. Published 22 times a year Genomika encompasses genomics, proteomics, bioinformatics, SNP analysis and more. Coverage includes:
Genomika is available electronically in a number of formats including PDF. For your free sample copy visit www.genomika.com or email genomika@pjbpubs.com |
 |
| The Journal of Biolaw & Business Profile to follow shortly. |
 |
| Pharmaprojects Pharmaprojects is the leading source of business-critical intelligence on drugs in global R&D providing users with a comprehensive and accurate view of drug development. Pharmaprojects tracks every significant new drug under development. It contains analysis on over 28000 drug candidates investigated since 1980 and detailed profiles on over 1300 companies and 217 therapeutic areas - enabling users to track the R&D activities of competitor companies, assess potential business partners, identify licensing opportunities, analyse industry trends and formulate R&D strategy. Committed to providing up-to-date intelligence, our editorial team of 20 scientists gather and research worldwide R&D information from sources including international scientific journals; conferences; stock brokerage & annual reports; company websites; press releases; online news agencies, and continuous two-way communication with our company contacts. For more information, call us on +44 (0)20 8332-8820 or email us at pharmaprojects.enquiry@pjbpubs.com or visit our website. |
 |
| Scrip Reports Scrip Reports, a division of PJB Publications Limited, provide the highest standard of focused business intelligence in the pharmaceutical industry. With over 30 new titles per year, the reports cover strategic management issues, enabling technologies, therapeutics, drug discovery, biotechnology, regulatory affairs and e-commerce. An exciting new title from Scrip Reports' Biotechnology Series is Investing in Biotechnology - Financial Perspectives & Evaluation Strategies, published in June 2002. Linking venture capitalists, portfolio managers, biotechnology and pharmaceutical companies, this report provides a unique framework for the valuation of biotechnology companies. It covers the concepts and applications that will help the biotechnology industry get to grips with the finance industry, and vice versa. For more information, call us on +44 (0) 20 8332 8965/6 or email us at scripreports@pjbpubs.com, quoting Ref: BS1165, or visit our website. |
 |